Start-ups can find it an intimidating challenge when seeking access to the US marketplace through the FDA. 

MATRIX is “start-up friendly” and offers significantly lower fees for start-up and small companies. 

The US, the world’s largest market, is sometimes overlooked when companies decide to go to the EU first.  This is no longer an optimal strategy due to recent changes. 

1. There are only a handful of certified Notified
    Bodies to service the EU. 

2. Waiting times to get a submission approved by
    the EU is longer than ever. 

3. The US FDA now provides greater transparency
    and access through the 
Pre-Submission process.
    This means companies can gain critical  
    information required for future submissions in

MATRIX offers its experience and contacts over the past 25 years to start-ups at reduced costs. 

Start-Up Companies / use this discount code  456